Dresden
UKD Dresden
Selective delivery of Toll-like receptor 3 agonists for in situ vaccination in orthotopic gliomas
Development of large-scale expansion protocol for NKG2C-positive NK cells for treatment of glioblastoma
Selective delivery of Toll-like receptor 3 agonists for in situ vaccination in orthotopic gliomas
Blocking TIGIT to improve the cytotoxicity of in vitro expanded NK cells towards primary glioblastoma cells